CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. CELZ
Nasdaq · stock · Biological Products, (No Diagnostic Substances) · website · IPO 2009-05-01
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 63.4% | 60.0% | 60.0% | 67.8% | 45.4% | 69.2% | 72.5% | 43.4% | -66.7% | — |
| Operating margin | -102380.2% | -52216.9% | -62445.9% | -11562.5% | -3562.2% | -677.7% | -682.9% | -895.7% | -24537.6% | — |
| Net margin | -99916.8% | -49940.7% | -58739.7% | -11449.3% | 21892.8% | -22082.2% | -5126.1% | -10977.2% | -55398.1% | — |
| Return on assets | -76.8% | -82.4% | -49.3% | -52.9% | 170.5% | -5060.8% | -1598.3% | -2861.9% | -1309.0% | -237.5% |
| Return on equity | -79.7% | -86.6% | -51.1% | -63.9% | 188.0% | 91.3% | 105.1% | 341.8% | 118.9% | 485.5% |
| Debt / equity | — | — | — | — | — | — | — | — | -0.22× | — |
| Current ratio | 25.97 | 18.73 | 27.65 | 5.64 | 10.22 | 0.00 | 0.01 | 0.07 | 0.01 | 0.49 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.